The northeastern part of the United States is approaching the annual
respiratory syncytial virus (RSV) season, which
is November 2016 through March 2017. RSV is the most common cause of
bronchiolitis and pneumonia among
children younger than one year. During RSV season, Independence will approve
the monthly administration of
Synagis® for children in accordance with the most recent
recommendations from the American Academy of Pediatrics
(AAP).
It is mandatory for all participating providers to obtain
Synagis® through ACRO Pharmaceutical Services., an independent
company.
The October 2016 edition of Partners in Health UpdateSM
will include detailed information about how to order Synagis®,
as well as the complete list of recommendations for Synagis®
from the AAP. If you have questions about the Synagis®
distribution program, please contact Customer Service at 1-800-ASK-BLUE
.
This is not a statement of benefits. Benefits may vary
based on state requirements, Benefits Program (HMO, PPO, etc.), and/or employer
groups.
Providers should use the NaviNet® web portal to view the
member?s applicable benefits information. Members should be instructed to call
the
Customer Service telephone number listed on their ID card.
NaviNet is a registered trademark of NaviNet, Inc., an
independent company.